AdaptHealth Reports Fourth Quarter and Full-Year 2021 Results and Updates 2022 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
AdaptHealth (AHCO) PT Lowered to $20 at Stifel
February 24, 2022 1:50 PM ESTStifel analyst Mathew Blackman lowered the price target on AdaptHealth (NASDAQ: AHCO) to $20.00 (from $40.00) while maintaining a Buy rating.
... MoreAdaptHealth Corp. (AHCO) Misses Q4 EPS by 19c, Revenue Beats, Offers Guidance
February 24, 2022 6:44 AM ESTAdaptHealth Corp. (NASDAQ: AHCO) reported Q4 EPS of $0.15, $0.19 worse than the analyst estimate of $0.34. Revenue for the quarter came in at $702.1 million versus the consensus estimate of $689.66 million.
GUIDANCE:
AdaptHealth Corp. sees FY2022 revenue of $2.825-3.025 billion, versus the consensus of... More
